321 related articles for article (PubMed ID: 8838035)
1. Somatostatin and its analogues in G.I. tract, liver and pancreatic disorders.
Dhar A; Chawla YK
Trop Gastroenterol; 1995; 16(3):3-7. PubMed ID: 8838035
[No Abstract] [Full Text] [Related]
2. Octreotide.
Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
[No Abstract] [Full Text] [Related]
3. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
Feu F; Bosch J
Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
[No Abstract] [Full Text] [Related]
4. [Application of preparations--analogues of somatostatin in surgical pancreatology].
Kopchak VM; Kostylev MV; Kopchak KV; Egorova ON; Khomiak IV; Duvalko AV; Romaniv IaV; Pererva LA
Klin Khir; 2008 Jan; (1):18-21. PubMed ID: 18610850
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California.
Am J Med; 1986 Dec; 81(6B):1-101. PubMed ID: 2879445
[No Abstract] [Full Text] [Related]
6. Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide.
Grosman I; Simon D
Am J Gastroenterol; 1990 Sep; 85(9):1061-72. PubMed ID: 1975156
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues reduce liver volume in polycystic liver disease.
van Keimpema L; de Man RA; Drenth JP
Gut; 2008 Sep; 57(9):1338-9. PubMed ID: 18719151
[No Abstract] [Full Text] [Related]
8. Somatostatin and the gastrointestinal tract.
Tulassay Z
Scand J Gastroenterol Suppl; 1998; 228():115-21. PubMed ID: 9867121
[TBL] [Abstract][Full Text] [Related]
9. [Somatostatin in the treatment of pancreatic diseases].
Németh AM
Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
[TBL] [Abstract][Full Text] [Related]
10. [Somatostatin and octreotide in therapy of gastrointestinal diseases].
Stöckmann F
Z Gastroenterol Verh; 1991 Mar; 26():166-70. PubMed ID: 1714136
[No Abstract] [Full Text] [Related]
11. [Biotherapy of neuroendocrine tumours of the gastrointestinal tract and pancreas].
Hansen CP; Knigge U
Ugeskr Laeger; 2008 Jun; 170(24):2145-8. PubMed ID: 18565299
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
Masclee AA; Jansen JB; Lamers CB
Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
[No Abstract] [Full Text] [Related]
13. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
Friess H; Büchler MW
Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of intestinal hemorrhage in portal hypertension].
Sauerbruch T; Schiedermaier P
Dtsch Med Wochenschr; 1998 May; 123(20):633-6. PubMed ID: 9627572
[No Abstract] [Full Text] [Related]
15. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
Delmont J; Hastier P; Dumas R
Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
[No Abstract] [Full Text] [Related]
16. Can somatostatin derivatives really be suggested in the treatment of chylothorax?
Bernet-Buettiker V
Pediatr Crit Care Med; 2007 May; 8(3):308; author reply 308-9. PubMed ID: 17496524
[No Abstract] [Full Text] [Related]
17. Octreotide and enterocutaneous fistula closure in neonates and children.
Carrera-Guermeur N; Martín-Crespo RM; Ramírez HJ; Pantoja Á; Luque-Mialdea R
Eur J Pediatr; 2016 Mar; 175(3):305-12. PubMed ID: 26811298
[TBL] [Abstract][Full Text] [Related]
18. [Effect of enzyme therapy on food tolerance and digestive disorders].
Gullatz P
Landarzt; 1968 Nov; 44(33):1635-8. PubMed ID: 5717136
[No Abstract] [Full Text] [Related]
19. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
[TBL] [Abstract][Full Text] [Related]
20. Chronic octreotide therapy can induce pancreatic insufficiency: a common but under-recognized adverse effect.
Saif MW; Larson H; Kaley K; Shaib W
Expert Opin Drug Saf; 2010 Nov; 9(6):867-73. PubMed ID: 20662741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
